Dexmedetomidine: Sedative of Choice in Substance Abuse

Mohammed, Aasim; Maheshwari, Ana; Manns, Stephenie

doi:10.1016/j.chest.2016.08.238

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Elevation of blood pressure and catecholamine levels along with elevated plasma catecholamines is also seen. A recent study showed that use of dexmedetomidine in patients with substance abuse had shorter ICU and ventilator-dependent days [20]. The patients with substance abuse also had beneficial effect from anxiolytic and analgesic effects of dexmedetomidine without respiratory depression.…”

Section: Abuse and Dependencementioning

confidence: 99%

Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain

Kaye

Chernobylsky

Thakur

et al. 2020

Curr Pain Headache Rep

169

111

View full text Add to dashboard Cite

Purpose of Review Effective acute pain management has evolved considerably in recent years and is a primary area of focus in attempts to defend against the opioid epidemic. Persistent postsurgical pain (PPP) has an incidence of up to 30-50% and has negative outcome of quality of life and negative burden on individuals, family, and society. The 2016 American Society of Anesthesiologists (ASA) guidelines states that enhanced recovery after surgery (ERAS) forms an integral part of Perioperative Surgical Home (PSH) and is now recommended to use a multimodal opioid-sparing approach for management of postoperative pain. As such, dexmedetomidine is now being used as part of ERAS protocols along with regional nerve blocks and other medications, to create a satisfactory postoperative outcome with reduced opioid consumption in the Post anesthesia care unit (PACU). Recent Findings Dexmedetomidine, a selective alpha 2 agonist, possesses analgesic effects and has a different mechanism of action when compared with opioids. When dexmedetomidine is initiated at the end of a procedure, it has a better hemodynamic stability and pain response than ropivacaine. Dexmedetomidine can be used as an adjuvant in epidurals with local anesthetic sparing effects. Its use during nerve blocks results in reduced postoperative pain. Also, local infiltration of IV dexmedetomidine is associated with earlier discharge from PACU. Summary Perioperative use of dexmedetomidine has significantly improved postoperative outcomes when used as part of ERAS protocols. An in-depth review of the use of dexmedetomidine in ERAS protocols is presented for clinical anesthesiologists.

show abstract

Section: Abuse and Dependencementioning

confidence: 99%